Tamoxifen in refractory ovarian cancer: The use of a loading dose schedule

British Journal of Cancer

Volumn 57, Issue 1, 1988, Pages 115-116

  Osborne, R J ^a   Malik, S T ^a   Slevin, M L ^a   Harvey, V J ^b   Spona, J ^c   Salzer, H ^c   Williams, C J ^d  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c UNIVERSITY OF VIENNA   (Austria)

^d ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OVARY CANCER; PRELIMINARY COMMUNICATION;

AGED; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; MIDDLE AGE; OVARIAN NEOPLASMS; TAMOXIFEN;

EID: 0023853557     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1988.22     Document Type: Article

References (17)

1. BACKSTROM, T., MAHLCK, C.G. & KJELLGREN, O. (1983). Progesterone as a possible tumour marker for non endocrine ovarian malignant tumours. Gynecol. Oncol., 16, 129.
2. CAMPBELL, J.J., ROME, R.M., QUINN, M.A., PEPPERELL, R.J. & MORGAN, W.J. (1984). Tamoxifen for recurrent progressive epithelial ovarian tumours. Proc. XI Clin. Oncol. Soc. Australia. Abstract 73.
3. HAMERLYNCK, J.V.T.H., VERMORKEN, J.B., VAN DER BURG, M.E.L. & 5 others (1985). Phase II study of tamoxifen in advanced ovarian cancer. Proc. 3rd Eur. Conf. Clin. Oncol., 43 (Abstr.)
4. HAMILTON, T.C., DAVIES, P. & GRIFFITHS, K. (1981). Androgen and oestrogen binding in cytosols of human ovarian tumours. J. Endocrinol., 90, 421.
5. HEINONEN, P.K., TUIMALA, R., PYYKKO, K. & PYSTYNEN, P. (1982). Peripheral venous concentrations of oestrogens in post menopausal women with ovarian cancer. Br. J. Obstet. Gyne., 89, 84.
6. HOLT, J.A., CAPUTO, T.A., KELLY, K.M., GREENWALD, P. & CHOROST, S. (1979). Estrogen and progestin binding in cytosols of ovarian adenocarcinomas. Obstet. Gyneacol., 53, 50.
7. LANDONI, F., GHELARDONI, C., ZANINI, A. & COLOMBO, N. (1983). Tamoxifen in advanced epithelial ovarian cancer. J. Steroid. Biochem., 19, 935.
8. MILLER, A.B., HOOGSTRATEN, B., STAQUET, M. & WINKLER, A. (1981). Reporting results in cancer treatment. Cancer, 47, 207.
9. MYERS, A.M., MOORE, G.E. & MAJOR, F.J. (1981). Advanced ovarian carcinoma. Response to anti-oestrogen therapy. Cancer, 48, 2368.
10. PAGEL, J., ROSE, C., THORPE, S. & HALD, I. (1983). Treatment of advanced ovarnian carcinoma with tamoxifen. A phase II trial. Proc. 2nd Eur. Conf. Clin. Oncol. Amsterdam 05-29 (Abstr.)
11. ROWLAND, K., BONOMI, P., WILBANKS, G., YORDAN, E., GRAHAM, J. & DUNNE, C. (1985). Hormone receptors in ovarian carcinoma. Proc. Amer. Soc. Clin. Oncol., C-456 (Abstr.)
12. RUNGE, H.M., TEUFEL, G., NEULEN, J., GEYER, H. & PFLEIDERER, A. (1986). In vitro responsiveness of ovarian epithelial carcinoma to endocrine therapy. Cancer Chemother. Pharmacol., 16, 58.
13. SCHWARTZ, P.E., KEATING, G., MACLUSKY, N., NAFTOLIN, F. & EISENFELD, A. (1982). Tamoxifen therapy for advanced ovarian cancer. Obstet. Gynaecol., 59, 583.
14. SHIREY, D.R., KAVANAGH, J., GERSHENSON, D.M., FREEDMAN, R.S., COPELAND, L.J. & JONES, L.A. (1985). Tamoxifen therapy of epithelial ovarian cancer. Obstet. Gynaecol., 66, 575.
15. SLEVIN, M.L., HARVEY, V.J., OSBORNE, R.J., SHEPHERD, J.H., WILLIAMS, C.J. & MEAD, G. (1986). A Phase II study of tamoxifen in ovarian carcinoma. Eur. J. Cancer Clin. Oncol., 22, 309.
16. SUTTON, G.P., SENIOR, M.B., STRAUSS, J.F. & MIKUTA, M.D. (1986). Oestrogen and progesterone receptors in epithelial ovarian malignancies. Gynecol. Oncol., 23, 176.
17. WILKINSON, P.M., RIBIERO, G.G., ADAM, H.K., KEMP, J.V. & PATTERSON, J.S. (1982). Tamoxifen (Nolvadex) therapy - rationale for loading dose followed by maintenance dose for patients with metastatic breast cancer. Cancer Chemother. Pharmacol., 10, 33.